Novartis to shed 2,000 global jobs
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Novartis has announced plans to cut around 2,000 jobs, with its Swiss and US operations bearing the brunt of the move.
The company, which has already cut thousands of jobs, said the plans would be put in place over the next three to five years. The measures, which come as Novartis attempts to deal with growing price pressures and the strength of the Swiss franc, will affect 1.7 per cent of the firm's global workforce and is aimed at extracting $200m in annual savings. Alongside the cuts, Novartis announced an 18 per cent rise in third quarter net sales to $14.8bn.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments